Free Trial
OTCMKTS:IPAH

Interpharm (IPAH) Stock Price, News & Analysis

About Interpharm Stock (OTCMKTS:IPAH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Interpharm Holdings, Inc. (OTCMKTS:IPAH) was a specialty pharmaceutical company focused on the development, manufacture and marketing of generic prescription medicines. Its business included producing lower-cost alternatives to branded drugs for distribution through pharmaceutical wholesalers, pharmacies and other healthcare channels.

The company’s historical product portfolio included generic medicines in several therapeutic categories, including antidepressants, cardiovascular treatments, pain and anti-inflammatory therapies, and other prescription products. Interpharm also pursued product development and regulatory approval activities associated with bringing generic drugs to market.

Interpharm was based in the United States and primarily served the domestic pharmaceutical market. Reliable current information about the company’s operations, leadership and present business activities is limited, so its historical activities are described here without assuming that they continue today.

AI Generated. May Contain Errors.

Receive IPAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpharm and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IPAH Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Company Calendar

Today
10/31/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:IPAH
CIK
N/A
Employees
670
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
68.62
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:IPAH) was last updated on 10/30/2026 by MarketBeat.com Staff.
From Our Partners